AI is rapidly becoming foundational infrastructure in healthcare. According to PitchBook’s 2026 Artificial Intelligence Outlook, ambient AI scribes have emerged as the most commercially successful AI healthtech subsector in 2025, driven by clear ROI from reducing clinical documentation burden and administrative overhead. Platforms like Abridge, Ambience, and Suki AI are giving providers back their most valuable resource: time. This shift is not only improving clinician satisfaction but directly enhancing care delivery by allowing physicians to focus more fully on patients rather than paperwork.

The most transformational AI opportunity in healthcare is now unfolding in drug discovery:

• AI-enabled drug discovery tools are projected to grow from a $1.6B market in 2025 to $60B by 2030
• Clinical trial success rates could double from 8% to 17%, dramatically improving the odds of bringing new therapies to market
• AI is accelerating target identification, molecule design, trial optimization, and lab automation
• Faster development timelines and lower capital risk could reset the entire biotech innovation model
• This shift directly supports precision medicine, early detection, and preventative care at scale

At the same time, not all AI in healthcare will be winners. Second-tier AI medical scribe platforms are now considered overheated, with intense competition and growing pressure from major EHR incumbents embedding native AI directly into core systems. It’s clear that durable value in healthtech AI will be built on proprietary data, deep clinical workflow integration, regulatory alignment, and true outcome improvement.

Looking ahead, analysts believe healthcare must ultimately adopt an AI-first operating model, from care delivery and diagnostics to revenue cycle management and population health. Traditional tech-enabled healthcare services that fail to integrate AI at the core risk being fully displaced over the next decade.

For investors, this reinforces that the most enduring returns will come from companies that pair AI with commercialization discipline, regulatory rigor, and measurable patient impact. At Seed Healthcare, we believe AI is redefining what early detection, prevention, and precision care will look like for the next generation.